• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Novel VCAN mutations and evidence for unbalanced alternative splicing in the pathogenesis of Wagner syndrome.新型 VCANG1 突变及 Wagner 综合征发病机制中不平衡剪接的证据。
Eur J Hum Genet. 2013 Mar;21(3):352-6. doi: 10.1038/ejhg.2012.137. Epub 2012 Jun 27.
2
Erosive vitreoretinopathy and wagner disease are caused by intronic mutations in CSPG2/Versican that result in an imbalance of splice variants.糜烂性玻璃体视网膜病变和瓦格纳病由CSPG2/多功能蛋白聚糖的内含子突变引起,这些突变导致剪接变体失衡。
Invest Ophthalmol Vis Sci. 2006 Aug;47(8):3565-72. doi: 10.1167/iovs.06-0141.
3
Mutational hot spot potential of a novel base pair mutation of the CSPG2 gene in a family with Wagner syndrome.患有瓦格纳综合征的一个家族中CSPG2基因新型碱基对突变的突变热点潜力
Arch Ophthalmol. 2009 Nov;127(11):1511-9. doi: 10.1001/archophthalmol.2009.273.
4
A new VCAN/versican splice acceptor site mutation in a French Wagner family associated with vascular and inflammatory ocular features.在一个与血管性和炎症性眼部特征相关的法国家庭中发现的一种新的VCAN/多功能蛋白聚糖剪接受体位点突变。
Mol Vis. 2011;17:1669-78. Epub 2011 Jun 22.
5
Identification of a novel splice site mutation of the CSPG2 gene in a Japanese family with Wagner syndrome.在一个患有瓦格纳综合征的日本家族中鉴定CSPG2基因的一种新型剪接位点突变。
Invest Ophthalmol Vis Sci. 2005 Aug;46(8):2726-35. doi: 10.1167/iovs.05-0057.
6
Is exon 8 the most critical or the only dispensable exon of the VCAN gene? Insights into VCAN variants and clinical spectrum of Wagner syndrome.外显子 8 是 VCAN 基因中最关键还是唯一可有可无的外显子?对 VCAN 变异体和 Wagner 综合征临床谱的深入了解。
Am J Med Genet A. 2018 Aug;176(8):1778-1783. doi: 10.1002/ajmg.a.38855. Epub 2018 Jul 28.
7
Identification of Novel Copy Number Variations of VCAN Gene in Three Chinese Families with Wagner Disease.鉴定三个 Wagner 病中国家系中 VCANG 基因的新型拷贝数变异。
Genes (Basel). 2020 Aug 25;11(9):992. doi: 10.3390/genes11090992.
8
A novel splicing variant of VCAN identified in a Chinese family initially diagnosed with familial exudative vitreoretinopathy.在中国一个最初被诊断为家族性渗出性玻璃体视网膜病变的家系中鉴定到一种 VCAN 的新剪接变异体。
Mol Genet Genomic Med. 2023 Feb;11(2):e2083. doi: 10.1002/mgg3.2083. Epub 2022 Nov 5.
9
Deletions Overlapping VCAN Exon 8 Are New Molecular Defects for Wagner Disease.重叠于VCAN外显子8的缺失是瓦格纳病新的分子缺陷。
Hum Mutat. 2017 Jan;38(1):43-47. doi: 10.1002/humu.23124. Epub 2016 Nov 23.
10
Identification of the genetic defect in the original Wagner syndrome family.原始瓦格纳综合征家族中基因缺陷的鉴定。
Mol Vis. 2006 Apr 17;12:350-5.

引用本文的文献

1
Connecting the dots: the role of genetics in posterior vitreous detachment.理清头绪:遗传学在玻璃体后脱离中的作用
Graefes Arch Clin Exp Ophthalmol. 2025 Jun 18. doi: 10.1007/s00417-025-06869-8.
2
Protein -Fucosyltransferases: Biological Functions and Molecular Mechanisms in Mammals.蛋白质岩藻糖基转移酶:哺乳动物中的生物学功能与分子机制
Molecules. 2025 Mar 26;30(7):1470. doi: 10.3390/molecules30071470.
3
Discovery of immunotherapy targets for pediatric solid and brain tumors by exon-level expression.通过外显子水平表达发现儿科实体瘤和脑肿瘤的免疫治疗靶点
Nat Commun. 2024 May 3;15(1):3732. doi: 10.1038/s41467-024-47649-y.
4
Discovery of immunotherapy targets for pediatric solid and brain tumors by exon-level expression.通过外显子水平表达发现儿科实体瘤和脑肿瘤的免疫治疗靶点。
Res Sq. 2024 Jan 5:rs.3.rs-3821632. doi: 10.21203/rs.3.rs-3821632/v1.
5
mRNA splicing is modulated by intronic microRNAs.信使核糖核酸剪接受内含子微小核糖核酸调控。
iScience. 2023 Aug 28;26(10):107723. doi: 10.1016/j.isci.2023.107723. eCollection 2023 Oct 20.
6
Chemical, Molecular, and Single-nucleus Analysis Reveal Chondroitin Sulfate Proteoglycan Aberrancy in Fibrolamellar Carcinoma.化学、分子和单核分析揭示纤维板层癌中软骨素硫酸盐蛋白聚糖异常。
Cancer Res Commun. 2022 Jul 18;2(7):663-678. doi: 10.1158/2767-9764.CRC-21-0177. eCollection 2022 Jul.
7
Circular RNA Circ-0002570 Accelerates Cancer Progression by Regulating VCAN MiR-587 in Gastric Cancer.环状RNA Circ-0002570通过调控胃癌中的VCAN MiR-587促进癌症进展。
Front Oncol. 2021 Oct 6;11:733745. doi: 10.3389/fonc.2021.733745. eCollection 2021.
8
Congenital Disorders of Deficiency in Glycosaminoglycan Biosynthesis.糖胺聚糖生物合成缺陷的先天性疾病
Front Genet. 2021 Sep 3;12:717535. doi: 10.3389/fgene.2021.717535. eCollection 2021.
9
Differential expression and alternative splicing of transcripts in orbital adipose/connective tissue of thyroid-associated ophthalmopathy.甲状腺相关眼病眼眶脂肪/结缔组织中转录本的差异表达和可变剪接。
Exp Biol Med (Maywood). 2021 Sep;246(18):1990-2006. doi: 10.1177/15353702211017292. Epub 2021 Jun 2.
10
The versican-hyaluronan complex provides an essential extracellular matrix niche for Flk1 hematoendothelial progenitors.Versican-透明质酸复合物为 Flk1 血 - 内皮祖细胞提供了一个必不可少的细胞外基质小生境。
Matrix Biol. 2021 Mar;97:40-57. doi: 10.1016/j.matbio.2021.01.002. Epub 2021 Jan 14.

本文引用的文献

1
Systematic screening of FBN1 gene unclassified missense variants for splice abnormalities.针对 FBN1 基因未分类错义变异体进行剪接异常的系统筛查。
Clin Genet. 2012 Sep;82(3):223-31. doi: 10.1111/j.1399-0004.2011.01781.x. Epub 2011 Sep 30.
2
A new VCAN/versican splice acceptor site mutation in a French Wagner family associated with vascular and inflammatory ocular features.在一个与血管性和炎症性眼部特征相关的法国家庭中发现的一种新的VCAN/多功能蛋白聚糖剪接受体位点突变。
Mol Vis. 2011;17:1669-78. Epub 2011 Jun 22.
3
Gene therapeutic approach using mutation-adapted U1 snRNA to correct a RPGR splice defect in patient-derived cells.利用突变适应的 U1 snRNA 的基因治疗方法纠正患者来源细胞中的 RPGR 剪接缺陷。
Mol Ther. 2011 May;19(5):936-41. doi: 10.1038/mt.2011.7. Epub 2011 Feb 15.
4
A new mouse model for marfan syndrome presents phenotypic variability associated with the genetic background and overall levels of Fbn1 expression.一种新的马凡综合征小鼠模型表现出与遗传背景和 Fbn1 表达水平整体相关的表型变异性。
PLoS One. 2010 Nov 30;5(11):e14136. doi: 10.1371/journal.pone.0014136.
5
Remodelling of the human vitreous and vitreoretinal interface--a dynamic process.人玻璃体和玻璃体视网膜界面的重塑——一个动态过程。
Prog Retin Eye Res. 2010 Nov;29(6):580-95. doi: 10.1016/j.preteyeres.2010.07.001. Epub 2010 Jul 16.
6
Mutational hot spot potential of a novel base pair mutation of the CSPG2 gene in a family with Wagner syndrome.患有瓦格纳综合征的一个家族中CSPG2基因新型碱基对突变的突变热点潜力
Arch Ophthalmol. 2009 Nov;127(11):1511-9. doi: 10.1001/archophthalmol.2009.273.
7
Hyaluronan and chondroitin sulfate proteoglycans in the supramolecular organization of the mammalian vitreous body.哺乳动物玻璃体超分子结构中的透明质酸和硫酸软骨素蛋白聚糖。
Connect Tissue Res. 2008;49(3):124-8. doi: 10.1080/03008200802148496.
8
Clinical characterisation and molecular analysis of Wagner syndrome.瓦格纳综合征的临床特征及分子分析
Br J Ophthalmol. 2007 May;91(5):655-9. doi: 10.1136/bjo.2006.104406. Epub 2006 Oct 11.
9
Erosive vitreoretinopathy and wagner disease are caused by intronic mutations in CSPG2/Versican that result in an imbalance of splice variants.糜烂性玻璃体视网膜病变和瓦格纳病由CSPG2/多功能蛋白聚糖的内含子突变引起,这些突变导致剪接变体失衡。
Invest Ophthalmol Vis Sci. 2006 Aug;47(8):3565-72. doi: 10.1167/iovs.06-0141.
10
Identification of the genetic defect in the original Wagner syndrome family.原始瓦格纳综合征家族中基因缺陷的鉴定。
Mol Vis. 2006 Apr 17;12:350-5.

新型 VCANG1 突变及 Wagner 综合征发病机制中不平衡剪接的证据。

Novel VCAN mutations and evidence for unbalanced alternative splicing in the pathogenesis of Wagner syndrome.

机构信息

Institute of Medical Molecular Genetics, University of Zurich, Schwerzenbach, Switzerland.

出版信息

Eur J Hum Genet. 2013 Mar;21(3):352-6. doi: 10.1038/ejhg.2012.137. Epub 2012 Jun 27.

DOI:10.1038/ejhg.2012.137
PMID:22739342
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3573191/
Abstract

Wagner syndrome (WS) is an autosomal dominant vitreoretinopathy affecting various ocular features and is caused by mutations in the canonical splice sites of the VCAN gene, which encodes the large chondroitin sulfate proteoglycan, versican. We report the identification of novel splice acceptor and donor-site mutations (c.4004-1G>C and c.9265+2T>A) in two large WS families from France and the United Kingdom. To characterize their pathogenic mechanisms we performed qRT-PCR experiments on RNA from patient-derived tissues (venous blood and skin fibroblasts). We also analyzed RNA from the original Swiss family reported by Wagner (who has the previously reported c.9265+1G>A mutation). All three mutations resulted in a quantitative increase of transcript variants lacking exons 7 and/or 8. However, the magnitude of the increase varied between tissues and mutations. We discuss altered balance of VCAN splice variants in combination with reduction in glycosaminoglycan protein modifications as possible pathogenic mechanisms.

摘要

瓦格纳综合征(WS)是一种常染色体显性遗传性玻璃体视网膜病变,可影响多种眼部特征,由 VCANGENE 基因的典型剪接位点突变引起,该基因编码大型软骨素硫酸蛋白聚糖,即 versican。我们报道了在来自法国和英国的两个大型 WS 家族中鉴定出新型剪接受体和供体位点突变(c.4004-1G>C 和 c.9265+2T>A)。为了研究其致病机制,我们对源自患者组织(静脉血和皮肤成纤维细胞)的 RNA 进行了 qRT-PCR 实验。我们还分析了 Wagner 报道的原始瑞士家族的 RNA(该家族具有先前报道的 c.9265+1G>A 突变)。所有三种突变均导致缺乏外显子 7 和/或 8 的转录变体的定量增加。然而,增加的幅度在组织和突变之间有所不同。我们讨论了 VCAN 剪接变体平衡的改变与糖胺聚糖蛋白修饰的减少相结合作为可能的致病机制。